EGR1 and acute myeloid leukemia: Finally, by combining the ssGSEA scores for EGR1, BATF, and their target genes, we found that AML patients who had higher ssGSEA scores for EGR1 and its target genes, but lower ssGSEA scores for BATF and its target genes exhibited the most favorable prognosis (Fig. S3C).